Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
about
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboonsEffects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactonePhysical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine.Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital.Increases in Serum Growth Hormone Concentrations Associated with GHB Administration.Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability.Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.A brief history of 'new psychoactive substances'.Preparation of mixed-ion and inorganic perovskite films using water and isopropanol as solvents for solar cell applications
P2860
Q34209607-1427806B-FA22-41CC-890F-3980B4A1DBA8Q34285013-66DAE377-2010-46A9-8A6E-41125A1B2005Q35710620-E1ED9EAA-AB99-497F-90CB-D620FE64399DQ36539839-8FECD3D3-4049-4A69-9307-101A85DE5DFEQ36717113-2B0F58CC-C4D7-4130-91D1-AA5EFB71AA9EQ37033882-779AB8FE-C7FB-4179-9E0E-255EA8E057D4Q37224304-854F362D-BE37-4749-B6EF-0BB935B46337Q37291754-E3D6A259-9932-4269-8C85-44521582EF4EQ37976107-3120D0A3-0C5F-471F-8E6C-DB79D3D144EAQ38232868-84259868-C204-4D9D-AB67-B27BFFECE899Q42128375-42BF1160-AA92-4192-B226-FEFB4E0635CCQ43450955-B30FB9CB-07DB-45EF-8F5C-6033E8BE5233Q45195914-475EE1D6-9AEB-46C5-B46C-780AB5400AF7Q47378973-36731629-BA82-4A33-9BD1-93F5ACE8D303Q47379292-73F31267-E631-4D40-9B62-163BDF9FC66EQ47841359-F4685D4E-23C5-4CE2-A65B-FB324B687227Q48625700-05D0B510-1D9C-4B67-86E9-F29EBE04A5DEQ58414644-A15A2289-D5A1-48B5-A95E-C2D1F81AC515
P2860
Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acute toxicity and withdrawal ...... ) and 1,4-butanediol (1,4-BD).
@en
Acute toxicity and withdrawal ...... ) and 1,4-butanediol (1,4-BD).
@nl
type
label
Acute toxicity and withdrawal ...... ) and 1,4-butanediol (1,4-BD).
@en
Acute toxicity and withdrawal ...... ) and 1,4-butanediol (1,4-BD).
@nl
prefLabel
Acute toxicity and withdrawal ...... ) and 1,4-butanediol (1,4-BD).
@en
Acute toxicity and withdrawal ...... ) and 1,4-butanediol (1,4-BD).
@nl
P2860
P356
P1476
Acute toxicity and withdrawal ...... L) and 1,4-butanediol (1,4-BD)
@en
P2093
Paul I Dargan
P2860
P304
P356
10.1002/DTA.292
P577
2011-05-06T00:00:00Z